Science Explorer Back to mapMap
Discussion
Researcher · Fate Therapeutics (United States) · United States

Yu‐Waye Chu

Yu‐Waye Chu publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and HER2/EGFR in Cancer Research.

OpenAlex
World rank
#890,407
of 7,710,434 ranked researchers
Rank in United States
#294,100
of 1,627,098
Works
65
Citations
2.2k
Citations per work
34.2
h-index
24
i10-index 33Top 17% in Oncology
Yu‐Waye Chu

What does Yu‐Waye Chu research?

Yu‐Waye Chu's work is mostly in Medicine (61%), Immunology and Microbiology (13%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 40 works · 60.9% of their workMedicine: 40 works · 60.9% of their workOncology: 21 works · 32.2% of their workRadiology, Nuclear Medicine and Imaging: 10 works · 15.4% of their workPathology and Forensic Medicine: 6 works · 9.1% of their workEndocrinology, Diabetes and Metabolism: 3 works · 4.2% of their workLife Sciences: 14 works · 21.7% of their workImmunology and Microbiology: 9 works · 13.3% of their workImmunology: 9 works · 13.3% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 8.4% of their workMolecular Biology: 5 works · 8.4% of their workEverything else: 11 works · 17.4% of their workTHEIR WORKYu‐Waye Chu65works
Life Sciences22%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4060.9%
    1. Immunology and Microbiology913.3%
    2. Biochemistry, Genetics and Molecular Biology58.4%
  3. Everything else1117.4%
  1. 1Oncology32% of their works
  2. 2Radiology, Nuclear Medicine and Imaging15% of their works
  3. 3Immunology13% of their works
  4. 4Pathology and Forensic Medicine9% of their works
  5. 5Molecular Biology8% of their works
  6. 6Endocrinology, Diabetes and Metabolism4% of their works

Research topics

Which keywords describe Yu‐Waye Chu's research?

The keywords of their largest research topics: Lymphoma, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Fc Receptors, Therapeutic Antibodies, Breast Cancer and HER2.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Lymphoma332 topics
  2. Cancer Immunotherapy242 topics
  3. CAR T Cells211 topic
  4. Chimeric Antigen Receptor211 topic
  5. Fc Receptors201 topic
  6. Therapeutic Antibodies201 topic
  7. Breast Cancer151 topic
  8. HER2151 topic
  9. Classification121 topic
  10. Molecular Profiling121 topic
  11. NK Cell Recognition91 topic
  12. Natural Killer Cells91 topic
  13. Foxp361 topic
  14. TGF-ß61 topic
  15. Genome Engineering41 topic
  16. RNA-Guided41 topic
  17. Dendritic Cells31 topic
  18. Immunity31 topic

Where does Yu‐Waye Chu work?

Yu‐Waye Chu's main affiliation in the publication record is Fate Therapeutics (United States), United States.

How many publications and citations does Yu‐Waye Chu have?

OpenAlex counts 65 works and 2,222 citations for Yu‐Waye Chu, an h-index of 24, ranking #890,407 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yu‐Waye Chu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.